HPK1-IN-39 (Compound 10n), a selective inhibitor of Hematopoietic Progenitor Kinase 1 (HPK1) with an inhibitory concentration (IC50) of 29 nM, impedes the phosphorylation of SLP76. This compound is applicable in the research of cancer immunotherapy [1].
Molecular Weight:
469.54
Formula:
C26H27N7O2
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
